Cory Jubinville
Stock Analyst at LifeSci Capital
(1.87)
# 3,116
Out of 4,876 analysts
3
Total ratings
50%
Success rate
5.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics | Downgrades: Market Perform | $12 | $11.30 | +6.19% | 1 | Jun 18, 2025 | |
| MREO Mereo BioPharma Group | Initiates: Outperform | $10 | $2.66 | +275.94% | 1 | Dec 24, 2024 | |
| LQDA Liquidia | Initiates: Outperform | $30 | $13.10 | +129.01% | 1 | Oct 3, 2024 |
Verve Therapeutics
Jun 18, 2025
Downgrades: Market Perform
Price Target: $12
Current: $11.30
Upside: +6.19%
Mereo BioPharma Group
Dec 24, 2024
Initiates: Outperform
Price Target: $10
Current: $2.66
Upside: +275.94%
Liquidia
Oct 3, 2024
Initiates: Outperform
Price Target: $30
Current: $13.10
Upside: +129.01%